The Jewel Patch-WCD is designed to be worn continuously for up to a week at a time during normal daily activities, including showering. The Food and Drug Administration (FDA) has cleared the Jewel ® ...

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.

Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent ...

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.

Although no total cost is listed, labor alone is expected to cost at least $20 million and digital ads could cost tens of millions ...

The recall includes 7234 cases of juice, each with 24 bottles. The affected bottles have a "best by" date of December 5, 2026.

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital days, according to a study ...

At Sensient Technologies, one of the world’s largest dyemakers, scientists are working hard to find natural alternatives.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide).

The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.